Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 47, Issue 3, Pages 711-718
Publisher
Springer Science and Business Media LLC
Online
2021-10-20
DOI
10.1038/s41386-021-01170-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia
- (2021) Pejman Sehatpour et al. Frontiers in Psychiatry
- Identification of CVN058, a Novel Brain Penetrant, Selective 5-HT3 Receptor Antagonist That Shows Efficacy in Pre-Clinical Cognition Models
- (2021) Nicola Brice et al. BIOLOGICAL PSYCHIATRY
- Recent advances with 5‐HT 3 modulators for neuropsychiatric and gastrointestinal disorders
- (2020) Radomir Juza et al. MEDICINAL RESEARCH REVIEWS
- Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia
- (2020) Andrew D. Krystal et al. NATURE MEDICINE
- A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology
- (2020) Daniel C. Javitt et al. NEUROPSYCHOPHARMACOLOGY
- Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
- (2020) Joshua T. Kantrowitz CNS DRUGS
- Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia
- (2020) Kazutaka Ohi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats
- (2020) Maurizio S. Riga et al. NEUROPHARMACOLOGY
- The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial
- (2020) James Gilleen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study
- (2020) Joelle Choueiry et al. PSYCHOPHARMACOLOGY
- NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans
- (2019) Sara de la Salle et al. Frontiers in Pharmacology
- Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials
- (2019) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia
- (2019) Clément Dondé et al. Translational Psychiatry
- The thalamocortical circuit of auditory mismatch negativity
- (2019) Peter Lakatos et al. BIOLOGICAL PSYCHIATRY
- Neural and functional correlates of impaired reading ability in schizophrenia
- (2019) Clément Dondé et al. Scientific Reports
- New discoveries for an old drug: a review of recent olanzapine research
- (2019) Amir M Meftah et al. POSTGRADUATE MEDICINE
- The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT 3 receptor expressing interneurons: An in vitro study in rat hippocampus slices
- (2018) Elena Dale et al. BRAIN RESEARCH
- Gating of long-term potentiation (LTP) in the thalamocortical auditory system of rats by serotonergic (5-HT) receptors
- (2018) Karen K.Y. Lee et al. BRAIN RESEARCH
- Inhibitory circuit gating of auditory critical-period plasticity
- (2018) Anne E. Takesian et al. NATURE NEUROSCIENCE
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
- (2018) Daniel C. Javitt et al. JAMA Psychiatry
- Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
- (2018) Alan L. Pehrson et al. Frontiers in Pharmacology
- Ondansetron – a promising adjunctive treatment for persistent schizophrenia
- (2018) Jayashri Kulkarni et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
- (2018) Andrew D. Krystal et al. NATURE REVIEWS DRUG DISCOVERY
- Neural mechanisms of mismatch negativity dysfunction in schizophrenia
- (2017) M Lee et al. MOLECULAR PSYCHIATRY
- Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia
- (2017) Holly K Hamilton et al. SCHIZOPHRENIA BULLETIN
- Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia
- (2017) Michael L. Thomas et al. JAMA Psychiatry
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia
- (2017) Megan A. Perrin et al. SCHIZOPHRENIA RESEARCH
- A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia
- (2017) Migyung Lee et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia
- (2017) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia
- (2017) Michael Avissar et al. SCHIZOPHRENIA RESEARCH
- A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?
- (2016) Vibeke S. Catts et al. BIOLOGICAL PSYCHOLOGY
- Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
- (2016) Joshua T. Kantrowitz et al. BRAIN
- The effects of ketamine on the mismatch negativity (MMN) in humans – A meta-analysis
- (2016) Timm Rosburg et al. CLINICAL NEUROPHYSIOLOGY
- Derisking Psychiatric Drug Development
- (2016) Margaret C. Grabb et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Opening Holes in the Blanket of Inhibition: Localized Lateral Disinhibition by VIP Interneurons
- (2016) M. M. Karnani et al. JOURNAL OF NEUROSCIENCE
- Brain-Wide Maps of Synaptic Input to Cortical Interneurons
- (2016) N. R. Wall et al. JOURNAL OF NEUROSCIENCE
- Neostriatal GABAergic Interneurons Mediate Cholinergic Inhibition of Spiny Projection Neurons
- (2016) Thomas W. Faust et al. JOURNAL OF NEUROSCIENCE
- GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits
- (2016) Robin Tremblay et al. NEURON
- Involvement of 5-HT 3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission
- (2016) Maurizio S. Riga et al. NEUROPHARMACOLOGY
- Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders
- (2016) D. W. Volk et al. PSYCHOLOGICAL MEDICINE
- Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
- (2015) Daniel C. Javitt et al. AMERICAN JOURNAL OF PSYCHIATRY
- Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia
- (2015) Gregory A. Light et al. Annals of the New York Academy of Sciences
- Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia
- (2015) J. T. Kantrowitz et al. JOURNAL OF NEUROSCIENCE
- Auditory dysfunction in schizophrenia: integrating clinical and basic features
- (2015) Daniel C. Javitt et al. NATURE REVIEWS NEUROSCIENCE
- Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB)
- (2015) A. McCleery et al. PSYCHOLOGICAL MEDICINE
- Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlates in COGS-2
- (2015) Gregory A. Light et al. SCHIZOPHRENIA RESEARCH
- Reading Deficits in Schizophrenia and Individuals at High Clinical Risk: Relationship to Sensory Function, Course of Illness, and Psychosocial Outcome
- (2014) Nadine Revheim et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cortical interneurons that specialize in disinhibitory control
- (2013) Hyun-Jae Pi et al. NATURE
- Selective Serotonin 3 Receptor Antagonist Treatment for Schizophrenia: Meta-analysis and Systematic Review
- (2013) Taro Kishi et al. NEUROMOLECULAR MEDICINE
- Nonhuman primate model of schizophrenia using a noninvasive EEG method
- (2013) R. Gil-da-Costa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Auditory Emotion Recognition Impairments in Schizophrenia: Relationship to Acoustic Features and Cognition
- (2012) Rinat Gold et al. AMERICAN JOURNAL OF PSYCHIATRY
- Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness
- (2012) Derek J. Fisher et al. SCHIZOPHRENIA RESEARCH
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamatergic Modulation of Auditory Information Processing in the Human Brain
- (2011) Handan Gunduz-Bruce et al. BIOLOGICAL PSYCHIATRY
- Differential Relationships of Mismatch Negativity and Visual P1 Deficits to Premorbid Characteristics and Functional Outcome in Schizophrenia
- (2011) Tamara Friedman et al. BIOLOGICAL PSYCHIATRY
- Reduction in Tonal Discriminations Predicts Receptive Emotion Processing Deficits in Schizophrenia and Schizoaffective Disorder
- (2011) Joshua T. Kantrowitz et al. SCHIZOPHRENIA BULLETIN
- Translating Glutamate: From Pathophysiology to Treatment
- (2011) D. C. Javitt et al. Science Translational Medicine
- Mouse behavioral endophenotypes for schizophrenia
- (2010) Laura C. Amann et al. BRAIN RESEARCH BULLETIN
- The Largest Group of Superficial Neocortical GABAergic Interneurons Expresses Ionotropic Serotonin Receptors
- (2010) S. Lee et al. JOURNAL OF NEUROSCIENCE
- The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study
- (2010) Robert S. Kern et al. SCHIZOPHRENIA RESEARCH
- Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
- (2010) Richard S.E. Keefe et al. SCHIZOPHRENIA RESEARCH
- Deviance-elicited Changes in Event-related Potentials are Attenuated by Ketamine in Mice
- (2008) Richard S. Ehrlichman et al. JOURNAL OF COGNITIVE NEUROSCIENCE
- Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
- (2008) Karsten Heekeren et al. PSYCHOPHARMACOLOGY
- Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial
- (2008) Shahin Akhondzadeh et al. SCHIZOPHRENIA RESEARCH
- Neurophysiological biomarkers for drug development in schizophrenia
- (2007) Daniel C. Javitt et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started